Malaria (ongoing)

Malaria is arguably the disease that has killed more human beings than any other in all of history. For thousands of years — from ancient Egypt and Greece to the malaria-riddled trenches of World War I and the villages of sub-Saharan Africa today — Plasmodium parasites transmitted by female Anopheles mosquitoes have been humanity's most persistent biological enemy. By some estimates, half of all humans who have ever lived have died from malaria. Even restricting analysis to the 20th and 21st centuries, malaria has killed an estimated 70 million people while infecting billions more.

The disease is caused not by a single pathogen but by five species of Plasmodium parasite, of which Plasmodium falciparum is responsible for the vast majority of deaths. The parasite's lifecycle is elegantly lethal: it travels from mosquito saliva into the human bloodstream, invades liver cells where it multiplies invisibly, then erupts into the red blood cells — causing the classic cyclical fever pattern as waves of parasites are released every 48 to 72 hours. In severe cases, particularly in young children and pregnant women, parasites invade the brain (cerebral malaria), cause severe anaemia, or trigger multi-organ failure. Without treatment, severe malaria kills within days.

The geographic toll is brutally unequal. Sub-Saharan Africa bears roughly 95% of global malaria deaths, with children under five accounting for about 80% of fatalities on the continent. The reason is partly biological — adults in high-transmission areas develop partial immunity through repeated infection — and partly structural: the poorest communities lack access to insecticide-treated bed nets, indoor spraying, and anti-malarial medications. Countries like Nigeria, the Democratic Republic of Congo, Niger, Tanzania, and Mozambique each record hundreds of thousands of cases annually.

The 20th century saw dramatic swings in the fight against malaria. DDT-based eradication campaigns in the 1950s and 1960s eliminated malaria from Europe, North America, and much of South America and Asia. But in tropical Africa, where the Anopheles mosquito density is far higher and transmission occurs year-round, eradication proved impossible. The emergence of chloroquine-resistant Plasmodium falciparum in the 1970s and 1980s reversed hard-won gains, and deaths climbed sharply through the 1990s and early 2000s before a massive global response — funded largely by the Global Fund and the US President's Malaria Initiative — began to turn the tide.

Between 2000 and 2023, the global malaria death rate fell by roughly 60%, saving an estimated 12 million lives. But progress has stalled: since 2015, annual death counts have plateaued at around 600,000 per year, with COVID-19 disruptions pushing deaths back above 600,000 in 2020 and 2021. The development of the RTS,S/AS01 (Mosquirix) vaccine — approved by the WHO in 2021 after 30 years of development — and the more effective R21/Matrix-M vaccine (approved in 2023) offer new hope. But coverage remains limited, and climate change is expanding the range of Anopheles mosquitoes into higher altitudes and previously malaria-free regions. Malaria is not going away.